AnPac Bio Stock Gains On Robust Growth In Commercial Testing Volume In Q2

by Vandana Singh, Benzinga Editor

July 20, 2021 7:13 AM | 28 seconds read

AnPac Bio-Medical Science Co Ltd ANPC has announced strong growth in test volume in 1H of 2021. The total number of paid customers and testing volume increased almost 110% compared with 1H of 2020.
For 2Q, total paid tests and paid cancer tests increased approximately 280% Q/Q and around 270%, respectively.
The Company expects that the strong test volume growth will continue throughout this year.
Price Action: ANPC shares are up 9.5% at $4.39 during the premarket session on the last check Tuesday.

Posted In: Earnings News Penny Stocks Health Care General Briefs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.